Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.7020
+0.01562.27%
Post-market: 0.71860.0166+2.36%19:45 EDT
Volume:531.63K
Turnover:359.48K
Market Cap:87.65M
PE:-0.41
High:0.7400
Open:0.7077
Low:0.6371
Close:0.6864
Loading ...
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 27, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans